Skip to content

Percutaneous Transluminal Pulmonary Angioplasty for Patients with Chronic Pulomonary Thromboembolism

Percutaneous Transluminal Pulmonary Angioplasty for Patients with Chronic Pulomonary Thromboembolism - Percutaneous Transluminal Pulmonary Angioplasty for Patients with Chronic Pulomonary Thromboembolism

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001572
Enrollment
10
Registered
2009-01-12
Start date
2009-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary arterial hypertension due to chronic pulmonary thromboembolism

Interventions

Sponsors

Medical Education Center, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with chronic pulmonary thromboembolism who are refractory to other therapy and maladjustive for pulmonary endoarterectomy

Exclusion criteria

Exclusion criteria: patients who can not express subjective symptoms, whose objective improvement cannot be evaluated, who have systemic hypertension, who have bleeding complications, who have critical liver dysfunction, who are under pregnancy or breast-feeding, and who have critical left heart disease

Design outcomes

Primary

MeasureTime frame
symptom (NYHA classfication), 6 minutes walk test, right heart catheterization, computed tomography for evaluation of pulmonary artery, ventilation-perfusion scan, echocardiography

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026